Further, we performed in vitro studies of the effects of flavonolignans on mechanisms including the targets of the corresponding drugs—BRAF V600E kinase activity, the viability of A-375 human melanoma cells (with BRAF V600E mutation), and Hedgehog (HH) signaling pathway, including SMO. The gene discussed is BRAF; the disease is melanoma.